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Abstract
Neural tube defects (NTD5) in Hawaii between 1986 and 1997 were
examined using data from a statewide birth defects surveillance
system. The prevalence increased significantlyoverthe twelve-year
period. NTD prevalence did not appear to vary by place of resi
dence. The relationship of type of defect, maternal age, and infant/
fetus sex was similar to that reported in the literature.
Introduction
Neural tube defects (NTDs), a group of serious defects including
anencephaly, spina bifida, and encephalocele, are one of the most
common groups of birth defects in the United States, affecting
approximately one in every 1.000 births each year.1 Anencephaly is
almost invariably fatal. Anencephalic infants who are not stillborn
usually expire within several hours or days afterbirth. The prognosis
of an infant with spina bifida depends upon the lesion’s location and
the presence of other defects. An infant with spina bifida often has
some degree of limb paralysis or weakness and lack of bowel and
bladder control. The lifetime direct and indirect costs for each
person with spina bifida is estimated to be $300,000 (based on 1992
dollars), and the total medical costs for all individuals with spina
bifida account for approximately $500 million each year.2
The etiology of NTDs has been studied extensively, but is still not
completely understood. Both environmental and genetic factors are
known to affect their prevalence. The recurrence risk for NTDs is 3-
4 percent.3Racial/ethnic differences have been reported for NTDs,
with the defects most common among Hispanics. followed by non-
Hispanic whites, African-Americans, and Asians/Pacific Island
ers.1-’0The United States and other parts of the world have experi
enced a decline in the birth prevalence of NTDs over the last several
decades.1-51’2Some of this decline in NTD prevalence may be
attributed to the fact that, over the last several decades, prenatal
screening of maternal serum aipha-fetoprotein, human chorionic
gonadotropin. and unconjugated estriol and antenatal diagnosis with
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ultrasound have allowed a proportion of fetuses with NTDs to be
identified in utero and subsequently terminated, thus reducing the
birth prevalence of NTDs.’35 However, this decline was reported
prior to widespread prenatal screening and diagnosis and has been
observed in areas where elective termination is not allowed.
NTDs rates can vary widely from state to state5-’3 and between
regions within a state.’6 Reports of the influence of socioeconomic
status on NTD risk have been mixed.3 The risk for NTD has been
found to be highest among the youngest and/or oldest maternal age
groups.4-7’ Females are affected with NTDs more often than
1.l2,8
Maternal factors such as hyperthermia,’9diabetes,3-8obesity,2°and
valproic acid use3 have been associated with increased NTD risk.
Investigations have reported that maternal use of alcohol,3 caf
feine,2’ oral contraceptives,3contraceptive spermicides,22 ovula
tion-inducing drugs,23 and recreational drugs3 do not appear to
influence NTD prevalence while exposure to glycol ethers,24 radia
tion,25 arsenic,26hazardous waste sites,25-7 and drinking water con
taminants25 may increase NTD risk.
Maternal periconceptional consumption of folic acid (folate) has
been found to reduce NTD risk by as much as seventy percent.28The
exact mechanism through which this preventative effect operates is
unclear, although homocysteine metabolism has been suggested 29
In 1992, the U.S. Public Health Service recommended that all
women who can become pregnant consume 0.4mg of folic acid each
day. And as of January 1. 1998, all “enriched” cereal grains were
required by the U.S. Food and Drug Administration to be fortified
with folic acid. However, the recommendation and other activities
designed to increase public awareness of the importance of folic acid
in reducing NTD risk have resulted in only slight increases in
knowledge and folic acid consumption over initial low levels,28 and
it is too soon to evaluate the effectiveness of the fortification effort.
The purpose of this study was to examine the prevalence of
various NTD diagnostic categories with respect to selected demo
graphic factors such as year of delivery, infant/fetus sex and mater
nal race/ethnicity, age. and place of residence in Hawaii between
1986 and 1997.
Methods
Data were obtained from the Hawaii Birth Defects Program (HBDP),
an active, population-based surveillance registry for birth defects
for the entire state of Hawaii. The Program collects all pregnancies
regardless of outcome (livebirth, fetal death, elective termination)
and gestational age at the end of the pregnancy. Pregnancies of
interest are ascertained from diagnostic code lists and other reports
provided by all birth hospitals, facilities that perform elective
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terminations due to fetal anomaly, tertiary care hospitals, and all
clinics and laboratories in Hawaii that conduct prenatal diagnostic
tests and genetic counseling. In addition to diagnostic information
on each infant/fetus of interest, the HBDP collects data on demo
graphic factors, health behaviors, and other medical information
regarding the biological parents from the medical records.
The present study includes as cases all NTD-affected pregnancies
which ended in Hawaii between 1986 and 1997, inclusive. Any
cases where the diagnosis or place or type of pregnancy outcome
could not be confirmed were excluded from the analysis. Data
collected for each case included the type of NTD, end of pregnancy
year, maternal race/ethnicity, maternal age, residence at delivery,
and infant/fetus sex. Not all variables were available for every case,
so the sum of cases reported for a given variable may not equal the
total number of cases. Cases were sorted into diagnostic categories
of anencephaly, spina bifida, encephalocele, and total NTDs. Any
infant with more than one NTD was assigned to a single category in
the following descending order of priority: anencephaly, spina
bifida, encephalocele. No attempt was made to adjust for similar
times of conception between the livebirths/fetal deaths and the
elective terminations. Maternal race/ethnicity was assigned to one
of four groups: white (excluding Hispanic), Far East Asian (Japa
nese, Chinese, Korean), Pacific Islander (Hawaiian, Samoan, Gua
manian), and Filipino. Women with other or unknown race/ethnicity
(n=24) were excluded from the analysis of this particular demo
graphic factor. Women of mixed race/ethnicity were assigned to a
single race/ethnicity according to the following rules: 1) If two races
were noted and one was white, the other race was assigned; 2) If two
or more races were listed and one was Hawaiian, the assigned race
was Hawaiian; 3) If two or more races were listed and none of them
was Hawaiian, the first race listed was assigned, unless it was white,
in which case the second race was assigned.
The total prevalence for the twelve-year period and the prevalence
by two-year interval of delivery per 10,000 livebirths and fetal
deaths were calculated for each of the defect categories. For all other
demographic factors, rates per 10,000 livebirths alone were calcu
lated. Denominators were provided by the Hawaii State Department
of Health, Office of Health Status Monitoring, as derived from birth
and fetal death certificates. Secular trends were analyzed by the Chi
square tests for trend. Ninety-five percent confidence intervals were
calculated by Poisson probability.
Results
Two hundred forty-five NTD-affected pregnancies were identified
to have ended in Hawaii between 1986 and 1997, inclusive, for a
prevalence of 9.95 (95 percent confidence interval (CI) 8.74-1 1.28)
per 10,000 livebirths and fetal deaths. Of these cases, 89 (36.3
percent) were anencephaly, 111(45.3 percent) spina bifida, and 45
(18.4 percent) encephalocele. The prevalence for anencephaly and
spina bifida were similar (anencephaly 3.62, 95 percent CI 2.90-
4.45; spina bifida 4.51, 95 percent CI 3.7 1-5.43), while the preva
lence for encephalocele was significantly lower (1.83, 95 percent CI
1.33-2.45).
The rates of the various NTD diagnosis categories for each two-
year interval of the study are presented in figure 1. The rates for all
NTD categories increased over the twelve-year period of the study.
This trend was not statistically significantfor anencephaly (p=O.35l),
spina bifida (p=0.OS2), or encephalocele (p=O. 138), but was statis
tically significant for all NTDs combined (p=O.Ol2).
Table 1 shows the prevalence ofNTDs by maternal race/ethnicity.
The rate per 10,000 births for all NTDs combined was highest for
Pacific Islanders (11.59), followed by whites (11.32), Far East
Asians (9.81), and Filipinos (8.70). This pattern was not consistent
for individual NTD diagnoses. Far East Asians had the highest
Rate (per 10,000 livebirths and fetal deaths)
Figure 1.— Prevalence of neural tube defects (NTD5) by diagnosis, Hawaii 1986-1997
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prevalence of anencephaly (4.31) while Pacific Islanders had the
highest prevalence of spina bifida (5.87) and Filipinos of encepha
locele (2.17). However, none of the differences between the racial!
ethnic groups was statistically significant for any of the diagnostic
categories.
Maternal age demonstrated no clear pattern in risk for spina bifida.
_________
encephalocele, or all NTDs combined (table 2) although the highest
rates for spina bifida and encephalocele were among older women
(35.39 and >40 age groups, respectively). Anencephaly risk tended
to decline with increasing maternal age.
The numbers and rates of NTD-affected pregnancies by county of
residence and by metropolitan Honolulu versus the rest of the state
are exhibited in table 3 and table 4, respectively. The prevalence for
the various diagnostic categories was similar for all counties except
for Kauai County. which had a lower prevalence for anencephaly.
spina bifida, and total NTDs. Due to the small number of cases. this
decreased risk was not statistically significant. The rate was slightly
higher for all diagnostic categories except encephalocele for resi
dents of metropolitan Honolulu when compared to the rest of the
state.
Table 5 shows the distribution of NTDs by infantlfetus sex.
Females were disproportionally represented in all diagnostic cat
egories. This disparity was statistically significant for spina bifida
and total NTDs.
Discussion
The total prevalence for NIDs in Hawaii between 1986 and 1997
was 9.95 per 10,000 livebirths and fetal deaths. The prevalence rates
for anencephaly and spina bifida were similar (3.62 and 4.51,
respectively), while that for encephalocele was substantially lower
(1.83). These rates are similar to those observed in other studies
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Table 2.—Prevalence of neural tube defects (NTDs) by maternal age,
Hawai, 1986-1997.
Maternal age No. Rate* 95% Cl
Anenceohaly
19 13 5.65 3.01-9.65
20-24 16 2.64 1.51-4.29
25-29 33 5.03 3.46-7.06
30-34 22 4,24 2.66-6.42
35-39 5 2.12 0.69-4.96
>40 0 0.00 0.00-8.36
Spina bifida
<19 12 5.21 2.69-9.10
20-24 26 4.29 2.80-6.28
25-29 30 4.57 3.08-6.52
30-34 23 4.43 2.81-6.65
35-39 18 7.65 4.53-12.08
40 2 4.53 0.55-16.37
Encephalocele
19 3 1.30 0.27-3.81
20-24 12 1.98 1.02-3.46
25-29 17 2.59 1.51-4.14
30-34 7 1.35 0.54-2.78
35-39 3 1.27 0.26-3.72
40 3 6.80 1.40-19.86
Total NTDs
<19 28 12.16 8.08-17.57
20-24 54 8.91 6.69-11.62
25-29 80 12.18 9.66-15.16
30-34 52 10.03 7.49-13.15
35-39 26 11.05 7.22-16.18
40 5 11.34 3.68-26.43
*per 10,000 livebirths. **Cl confidence interval.
Table 1 .— Prevalence of neural tube defects (NTD5) by maternal race!
ethnicity, Hawal, 1986-1997.
Race/ethnicity No. Rate* 95% Cl
Anencephaly
white 23 3.67 2.32-5.50
FarEastAsian 18 4.31 2.55-6.81
Pacific Islander 23 3.65 2.31 -5.48
Filipino 12 2.90 1.50-5.06
Spina bifida
white 35 5.58 3.89-7.76
Far East Asian 15 3.59 2.01-5.92
Pacific Islander 37 5.87 4.14-8.09
Filipino 15 3.62 2.03-5.98
Encephalocele
white 13 2.07 1.10-3.54
Far East Asian 8 1.91 0.83-3.77
Pacific Islander 13 2.06 1.10-3.53
Filipino 9 2.17 0.99-4.13
Total NTDs
white 71 11.32 8.84-14.28
Far East Asian 41 9.81 7.04-13.30
Pacific Islander 73 11.59 9.08-14.57
Filipino 36 8.70 6.09-12.04
*per 10,000 iivebirths. **cl confidence interval.
Table 3.— Prevalence of neural tube defects (NTDs) by county of
residence, Hawaii, 1986-1997.
County No. Rate* 95% Cl
Anencephaly
Honolulu 68 3.86 3.00-4.89
Hawaii 10 4.28 2.05-7.86
Maui 7 3.53 1.42-7.27
Kauai 2 1.99 0.24-7.17
Spina bifida
Honolulu 79 4.48 3.55-5.58
Hawaii 11 4.70 2.35-8.41
Maui 12 6.05 3.13-10.57
Kauai 2 1.99 0.24-7.17
Encephalocele
Honolulu 34 1.93 1.34-2.69
Hawaii 7 2.99 1.20-6.17
Maui 2 1.01 0.12-3.64
Kauai 2 1.99 0.24-7.17
Total NTDs
Honolulu 181 10.27 8.83-11.87
Hawaii 28 11.97 7.96-17.30
Maui 21 10.59 6.56-16.18
Kauai 6 5.96 2.19-12.96
*per 10,000 livebirths. Cl, confidence interval.
conducted in the United States.458
In spite of the relatively small number of cases in a given year, the
NTD prevalence demonstrated a general tendency to increase over
the twelve-year period of the study. This trend was observed for all
of the NTD diagnosis categories and was statistically significant for
all NTDs combined. Among the specific NTD types, the increase
was lowest for anencephaly (slope =0.11), greatest for spina bifida
(slope = 0.25) and intermediate for encephalocele (slope = 0.12).
This observation runs counter to other recent studies that have
reported a decline in NTD prevalence in the United States.45,2A
number of these studies did not include electively terminated NTDs
in their analysis, while this one does. However, many of these other
studies did include time periods prior to when the prenatal diagnosis
and elective termination of NTD-affected pregnancies became
common practice and/or were able to take into account the impact of
elective termination to some degree.
Moreover, since 1992 various recommendations and other ac
tions, including the fortification of “enriched” cereal grains in the
U.S. in 1998, have been taken to increase knowledge and consump
tion of folic acid by women of childbearing age. As a result, NTD
rates would be expected to decline since the beginning of the decade.
However, neither a reduction in NTD prevalence specifically linked
to folic acid use nor more than slight improvements in women’s
awareness and consumption of folic acid have been reported.28
The prevalence trend observed by this study is not believed to be
based on biased ascertainment by the HBDP. Since its inception in
1989, the Program’s catchment area has not changed, nor has the
HBDP significantly modified its birth defects ascertainment proce
dures for livebirths. The data for years prior to 1989 were collected
retrospectively, but the same procedures were applied to these years
as for all others.
In 1992, the HBDP stopped systematically reviewing all medical
records on fetal deaths less than 20 weeks gestation unless a fetal
anomaly was suspected. However, if this change had had any impact
on NTD rates it would have been expected to cause a decrease in
trend and not an increase. Also, only four of the NTD cases had been
identified among fetal deaths less than 20 weeks gestation prior to
this change.
In 1993, the HBDP added elective terminations due to fetal
anomalies less than 20 weeks gestation to its study criteria. (Prior to
this time, only elective terminations 20 weeks or greater gestation
were included.) As with livebirth cases, data for earlier years were
ascertained retrospectively. Also, the increase in rates continued
after this date. Moreover, since the HBDP uses a multiple source
ascertainment system to identify cases, it is unlikely that NTD cases
of any pregnancy outcome would have been missed by all sources.
A very small number of NTDs were identified by the HBDP
prenatally, but the place and date of the end of the pregnancy could
not be determined. Since the HBDP has access to all facilities in
Hawaii where births and terminations due to fetal anomalies occur,
most likely these prenatally-diagnosed pregnancies did not end in
the state. Also, they were distributed throughout the twelve-year
period of interest and their numbers would be too small to affect the
observed trends appreciably.
Nor can the increase be accounted for by an increasing number of
non-residents coming to the state to deliver NTD-affected pregnan
cies. Nine of the NTD cases in the registry occurred to non-residents.
While seven of these cases occurred in the second half of the time
period under study and only two occurred in the first half, the
numbers are too small to account for the observed trend.
The observed increase in NTD prevalence in Hawaii could possi
bly result from some change in reporting practices by participating
facilities, such as a change in defect coding. However, the multiple
source system used by the HBDP would tend to minimize the impact
of such a change. And to date the researchers have failed to
positively identify a change in reporting practices.
The trend may represent a change in demographic patterns among
Hawaii’s population. However, the only identified change in demo
graphics observed in 1986-1997was a shift toward births to older
women. With the exception of anencephaly, this investigation failed
to identify any trend in maternal age risk. And for anencephaly, the
risk appeared to decrease with increasing maternal age.
Although some variation was observed in the prevalence of NTDs
between the racial/ethnic groups examined, the differences were
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Table 4.— Prevalence of neural tube defects (NTD5) by urbanity,
Hawai, 1986-1997.
Urbanity
Anencephaly
Metro Honolulu
Rest of Hi
No. Rate* 95% CI
27 404 2.66-5.88
60 3.71 2.83-4.77
Spina bifida
Metro Honolulu
Rest of Hi
33 4,94 3.40-6.94
71 4.39 3.435.53
Encephalocele
Metro Honolulu
Rest of Hi
13 1.95 1.04-3.33
32 1.98 1.35-2.79
Total NTDs
Metro Honolulu
Rest of Hi
Table 5.— Prevalence of neural tube defects (NTD5) by gender,
Hawal, 1986-1997.
Gender No. Rate* 95%CI**
Anencephaly
Male 26 2.21 1.44-3.23
Female 37 3.32 2.34-4.58
Spina bifida
Male 39 3.31 2.35-4.53
Female 66 ‘5.93 4.58-7.54
Enceohalocele
Male 17 1.44 0.84-2.31
Female 19 1.71 1.03-2.66
Total NTDs
Male 82 6.96 5.54-8.64
Female 122 10.96 9.10-13.08
*per 10,000 livebirths. **Cl confidence interval.
73 10.93 8.57-13.74
163 10.07 8.59-11.74
*per 10,000 livebirths. **CI confidence interval.
minor and in no instance statistically significant. Other studies had
observed the NTD prevalence to be lower in Asians than whites.57’9
However, these studies grouped Asians together as a single group,
thus blurring any differences between the various Asian race/ethnic
groups. while this study subdivided this large category. In this
investigation, whites did, in fact, demonstrate higher prevalence
than Far East Asians for all NTD categories except anencephaly.
Pacific Islanders had rates similar to whites, while, with the excep
tion of encephalocele. rates for Filipinos were lower than for whites.
One limitation of this analysis is that a large proportion of the
population of Hawaii is of mixed race/ethnicity. For the current
analysis. the researchers assigned women of mixed race/ethnicity to
a single racial/ethnic group, following the practices of the Hawaii
Department of Health. In doing so, racial/ethnic differences may
have been blurred. Unfortunately, the researchers cannot identify
those cases ofmixed-ancestry without reviewing the medical records
again. Nor can comparable denominators be easily obtained from
the Department of Health.
As mentioned above, anencephaly risk was found to decrease with
increasing maternal age. an observation consistent with that of prior
studies.17Also, this analysis did identify the highest prevalences for
spina bifida and encephalocele among the oldest maternal age
groups, something which other studies had found.4’7”However,
none of these observations was statistically significant.
Aside from encephalocele. NTD risk was much lower in Kauai
County, although this observation was not statistically significant.
The rates for all NTD categories were similar among the other three
counties and similar between metropolitan Honolulu and the rest of
the state.
Females were disproportionally more likely to have a NTD than
males. The degree of this disparity was not consistent between the
types of NTDs: the difference was highest for spina bifida and
lowest for encephalocele. The greater prevalence among females
observed in this study was in keeping with that found in the
literature.3’6’’ 12,16
The sex of forty-one (17 percent) of the NTD cases in the study
could not be determined. Most of these were cases which were
electively terminated and there was no mention of the fetus’ sex in
the medical record. However, sex was not found to affect the
decision to electively terminate an NTD-affected pregnancy. There
fore, the cases of unknown sex are not thought to differ significantly
from those cases of known sex and affect the sex ratio observed.
The main limitation of this study was its inability to determine a
concrete explanation for the apparent increase in prevalence of
NTDs in Hawaii between 1986 and 1997. Factors such as changes
in case ascertainment over time were eliminated, and, with the
possible exception of race/ethnicity. NTDs rates and patterns in
Hawaii were similar to those in other parts of the U.S. for the
demographic factors studied.
Due to the relatively small number of NTD cases observed by the
HBDP each year (11-34), the observed trend may be spurious, in
spite of the fact that it passed a test for statistical significance. Only
further surveillance and the observation of a continued increase in
prevalence would verify the results of this analysis. (And even if the
increase does not appear to continue, this would not eliminate the
possibility that the observed prevalence increase was true. The
factor causing the increase could have ceased to operate or its impact
mitigated by some other factor e.g., cereal grain fortification starting
in 1998.)
The researchers were restricted in the variables they could exam
ine in an effort to account for the secular increase to those which can
be easily and consistently extracted from medical records. These
records typically do not contain consistent and detailed information
on environmental factors and others such as folic acid consumption,
diet, and health behaviors which may affect NTD risk. Such infor
mation would perhaps be better obtained through a case-control
interview study or some other research methodology. Considering
the relatively small number of NTDs which occur each year. a case-
control study would likely have to be conducted over a relatively
long period of time.
The small number of cases likewise limited the analyses of the
other demographic factors. Few of the observed differences in
prevalence were found to be statistically significant. Only continued
collection of cases over additional years would likely increase the
statistical power of such analyses.
In conclusion, NTD rates and demographic factors such as race/
ethnicity, maternal age, and sex were analyzed and found to be
similar to that observed in other studies in the U.S. This study
identified a general increase in the prevalence of NTDs in Hawaii
between 1986 and 1997. No concrete explanation for the secular
trend could be determined. Further investigation is suggested.
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Classified Notices
To place a classified notice:
HMA members—Please send a signed and type
written ad to the HMA office. As a benefit of member
ship, HMA members may place a complimentary one
time classified ad in HMJ as space is available.
Nonmembers.—Please call 536-7702 for a non
memberform. Ratesare$1.5oawordwith aminimum
of 20 words or $30. Not commissionable. Payment
must accompany written order.
Office Space
ALA MOANA BLDG.—PHYSICIANS WANTEDto share
space and support services. Interest in physical rehab.
preferred. We have flexible rental arrangements start
ing atone half-day per week. Run your practice with no
fixed overhead. Contact Dr. Speers, REHABILITA
TION ASSOCIATES, 955-7244.
Wanted
PSYCHIATRIST.— Kaneohe residential Program for
adolescents seeks consultant two half-days per month.
Schedule, duties, compensation negotiable. Contact
Administrator: RAINBOW HOUSE 239-2399.
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Arleen D. Jouxson, Esq.
Attorney at Law
Wahiawa pediatrician since 1979
Associate Clinical Professor, JABSOM
A.K.A. Arlene Meyers,
MD, MPH
• 1998 Roscoe Pound award winner in health care law
• President & founder of the Hawaii Coalition For Health
NEED HELP?
with Par. Agreements?
• Understanding health care laws?
• Resolving disputes with health
insurers?
CALL 621-8806 (Oahu) for more information or for a free
initial consultation at your place of business.
302 California Ave., #209, Wahiawa, HI 96786, Ph: 621-8806; Fax: 622-5599
Why give up more!
WE COLLECT PAST
DUE ACCOUNTS
Only 25%* fee for
Health Care
Flims!
Wood & Tait
HI Collection & Detective Agency
Staff on Kauai, Oahu, Maui, & Hawaii
http://www.woodtait.com
739-0433
jwood@woodtait. corn
*Applies to accounts assigned during this pro
motion; no restrictions as to dollar size or age
of accounts. Fee will increase to 50% if litiga
tion or forwarding required; you will receive a
contract.
Janssen Pharmaceutica
Is proud to support the
Hawaii Medical Journal
World leader in antimycotic research
JANSSEN
Titusville, NJ 08560-0200
®1 998 Janssen Pharmaceutica
341
